These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6573318)

  • 1. Pharmacokinetics and tolerance of single intramuscular doses of cefotetan in normal Caucasian volunteers.
    Yates RA; Cockshott ID; Houghton HL; Wardleworth A; Adam H; Donnelly RJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():207-12. PubMed ID: 6573318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tolerance of single intravenous doses of cefotetan disodium in male Caucasian volunteers.
    Yates RA; Adam HK; Donnelly RJ; Houghton HL; Charlesworth EA; Laws EA
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():185-91. PubMed ID: 6573315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tolerance of a 24-h infusion of cefotetan disodium (with and without loading dose) in normal Caucasian volunteers.
    Adam HK; Houghton HL; Yates RA; Young J; Donnelly RJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():193-9. PubMed ID: 6573316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers.
    Guibert J; Kitzis MD; Yvelin C; Acar JF
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():201-6. PubMed ID: 6573317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefotetan (YM09330) in humans.
    Nakagawa K; Koyama M; Tachibana A; Komiya M; Kikuchi Y; Yano K
    Antimicrob Agents Chemother; 1982 Dec; 22(6):935-41. PubMed ID: 6961888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of cefotetan and an aminoglycoside preparation in combined administration. 1. Individual quantification of cefotetan and sisomicin by bioassay and their absorption, distribution, and excretion in rats when given together].
    Tachibana A; Ikeda C; Yano K
    Jpn J Antibiot; 1982 Jun; 35(6):1411-26. PubMed ID: 6957627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of cefotetan excretion in the unobstructed biliary tree.
    Owen AW; Manson JM; Yates RA; Adshead VM; Houghton HL; Tweedle DE
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():217-21. PubMed ID: 6573320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefotetan elimination in patients with varying degrees of renal dysfunction.
    Wright N; Wise R; Hegarty T
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():213-6. PubMed ID: 6573319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of cefotetan to Gram-negative beta-lactamases.
    Cocuzza G; Blandino G; Mattina R
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():139-45. PubMed ID: 6601653
    [No Abstract]   [Full Text] [Related]  

  • 10. The interactions of [14C]cefotetan with penicillin binding proteins of a wide variety of Gram-positive and gram-negative species.
    Nolan RD; Jude DA
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():169-77. PubMed ID: 6573313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function.
    Ohkawa M; Hirano S; Tokunaga S; Motoi I; Shoda R; Ikeda A; Sugata T; Sawaki M; Shimamura M; Okasho A; Kuroda K
    Antimicrob Agents Chemother; 1983 Jan; 23(1):31-5. PubMed ID: 6572490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of a cefotetan and an aminoglycoside preparation in combined administration. 2. Absorption and exercise of cefotetan and sisomicin in dogs when the two are given together].
    Ikeda C; Tachibana A; Yano K
    Jpn J Antibiot; 1982 Jun; 35(6):1427-36. PubMed ID: 6957628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Richards DM
    Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beta-lactamase stability and in vitro activity of cefotetan; a comparison with 8 other beta-lactam antibiotics and gentamicin.
    Friis H; Prag J; Togsverd E; Benzon MW
    Acta Pathol Microbiol Immunol Scand B; 1986 Aug; 94(4):251-6. PubMed ID: 3489350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Tolerability of Single and Multiple Intravenous Doses of Cefotetan Disodium in Healthy Chinese Volunteers.
    Liu J; Zhai Y; Wu L; Wu G; Zheng Y; Hu X; Shentu J
    Drug Des Devel Ther; 2020; 14():613-620. PubMed ID: 32103903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefotetan in elderly subjects after intramuscular administration.
    Ripa S; Mignini F; Prenna M
    Chemioterapia; 1987 Oct; 6(5):359-63. PubMed ID: 3480780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.
    Daschner FD; Goerke C; Bassler M; Just M
    Chemotherapy; 1982; 28(5):351-4. PubMed ID: 6958416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotetan pharmacokinetics in volunteers with various degrees of renal function.
    Smith BR; LeFrock JL; Thyrum PT; Doret BA; Yeh C; Onesti G; Schwartz A; Zimmerman JJ
    Antimicrob Agents Chemother; 1986 May; 29(5):887-93. PubMed ID: 3460524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary report on a comparative trial of cefotetan and cefoxitin in the treatment of urinary tract infections.
    Cox CE; Childs SJ; Wells WG; Mirelmant S; Lesky WC
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():227-32. PubMed ID: 6341350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefotetan disodium (Cefotan).
    Med Lett Drugs Ther; 1986 Jul; 28(718):70-2. PubMed ID: 3523182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.